The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma

Immunotherapy is a new treatment option for patients with esophageal squamous cell carcinoma (ESCC). However, no study has investigated the efficacy and safety of sintilimab combined with nanoparticle albumin-bound paclitaxel (Nab-PTX) and platinum as first-line treatment for metastatic ESCC. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zheng, Yin, Ming-Mei, Zhao, Wei-Feng, Wang, Chao-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443762/
https://www.ncbi.nlm.nih.gov/pubmed/37603519
http://dx.doi.org/10.1097/MD.0000000000034794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443762/
https://www.ncbi.nlm.nih.gov/pubmed/37603519
http://dx.doi.org/10.1097/MD.0000000000034794

Ejemplares similares